It does not predict response to any specific medication
Most importantly, understanding the timeline shifts your mindset
No significant difference was found in the followings when compared with placebo group, which were cardiovascular disorders, psychic disorders, allergic reactions, injection-site reactions ( Figures S2629 )
[1] [3] The combined effect may support more meaningful weight reduction, which is particularly beneficial for patients with obesity-related type 2 diabetes
For instance, the American Diabetes Association only recommends the use of GLP-1 drugs for weight loss for those with a body mass index, or BMI, of at least 30, or among those with a BMI of 27 or greater if they have at least one other condition such as type 2 diabetes, hypertension or high cholesterol